| For: | Yadav H, Jain S, Nagpal R, Marotta F. Increased fecal viral content associated with obesity in mice. World J Diabetes 2016; 7(15): 316-320 [PMID: 27555892 DOI: 10.4239/wjd.v7.i15.316] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v7/i15/316.htm |
| Number | Citing Articles |
| 1 |
Aneela Gulnaz, Jawad Nadeem, Jong-Hun Han, Lee-Ching Lew, Jae-Dong Son, Yong-Ha Park, Irfan A. Rather, Yan-Yan Hor. Lactobacillus Sps in Reducing the Risk of Diabetes in High-Fat Diet-Induced Diabetic Mice by Modulating the Gut Microbiome and Inhibiting Key Digestive Enzymes Associated with Diabetes. Biology 2021; 10(4): 348 doi: 10.3390/biology10040348
|
| 2 |
Geng-Hao Bai, Sheng-Chieh Lin, Yi-Hsiang Hsu, Shih-Yen Chen. The Human Virome: Viral Metagenomics, Relations with Human Diseases, and Therapeutic Applications. Viruses 2022; 14(2): 278 doi: 10.3390/v14020278
|
| 3 |
Felix Broecker, Giancarlo Russo, Jochen Klumpp, Karin Moelling. Stable core virome despite variable microbiome after fecal transfer. Gut Microbes 2017; 8(3): 214 doi: 10.1080/19490976.2016.1265196
|
| 4 |
Patrick Lee, Bruce R. Yacyshyn, Mary B. Yacyshyn. Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT). Diabetes, Obesity and Metabolism 2019; 21(3): 479 doi: 10.1111/dom.13561
|
| 5 |
Yun Tian, Jordan Jennings, Yuanying Gong, Yongming Sang. Viral Infections and Interferons in the Development of Obesity. Biomolecules 2019; 9(11): 726 doi: 10.3390/biom9110726
|
| 6 |
Chen Zeng, Sheng-Rong Wan, Man Guo, Xiao-Zhen Tan, Yan Zeng, Qi Wu, Jia-Jie Xie, Pijun Yan, Yang Long, Lemin Zheng, Zong-Zhe Jiang, Fang-Yuan Teng, Yong Xu. Fecal virome transplantation: A promising strategy for the treatment of metabolic diseases. Biomedicine & Pharmacotherapy 2024; 177: 117065 doi: 10.1016/j.biopha.2024.117065
|
| 7 |
Karin Moelling, Felix Broecker, Christian Willy. A Wake-Up Call: We Need Phage Therapy Now. Viruses 2018; 10(12): 688 doi: 10.3390/v10120688
|
| 8 |
Alexander Khoruts. Fecal microbiota transplantation–early steps on a long journey ahead. Gut Microbes 2017; 8(3): 199 doi: 10.1080/19490976.2017.1316447
|
| 9 |
Derek M. Lin, Henry C. Lin. A theoretical model of temperate phages as mediators of gut microbiome dysbiosis. F1000Research 2019; 8: 997 doi: 10.12688/f1000research.18480.1
|
| 10 |
Amir Gholamzad, Niloofar Khakpour, Seyed Mohammad Ali Hashemi, Yalda Goudarzi, Parisa Ahmadi, Mehrdad Gholamzad, Mahya Mohammadi, Mehrdad Hashemi. Exploring the virome: An integral part of human health and disease. Pathology - Research and Practice 2024; 260: 155466 doi: 10.1016/j.prp.2024.155466
|
| 11 |
Kosuke Fujimoto, Daichi Miyaoka, Satoshi Uematsu. Characterization of the human gut virome in metabolic and autoimmune diseases. Inflammation and Regeneration 2022; 42(1) doi: 10.1186/s41232-022-00218-6
|
| 12 |
Jiajia Duan, Wei Wang, Tao Jiang, Xiaoyang Bai, Chuanxin Liu. Viral metagenomics combined with metabolomics reveals the role of gut viruses in mouse model of depression. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.1046894
|
| 13 |
Zilu Cheng, Li Zhang, Ling Yang, Huikuan Chu. The critical role of gut microbiota in obesity. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1025706
|
| 14 |
Amjad Ahmadi, Leili Shokoohizadeh, Farshad Sheikhesmaili, Mohammadali Khan Mirzaei, Asadollah Mohammadi, Bahram Nikkhoo, Hakim Khodaei, Mohammad Yousef Alikhani, Rasoul Yousefimashouf. Gut microbiomes and treatment-resistant ulcerative colitis: a case-control study using qPCR. BMC Microbiology 2025; 25(1) doi: 10.1186/s12866-025-03963-z
|
| 15 |
Yingying Zhang, Ran Wang. The human gut phageome: composition, development, and alterations in disease. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1213625
|
| 16 |
Jing Zhang, Sujuan Wang, Dehan Luo, Xiaoxue Tian, Canlin Song, Yan Fu, Tenghui Zhang, Xin Zhao. Inhibitory effects of Lactobacillus fermentum TKSN02 isolated from Xinjiang cheese on obesity induced by high-fat diet in mice and its gut microbiota modulation effects. Applied Biological Chemistry 2025; 68(1) doi: 10.1186/s13765-025-01049-y
|
| 17 |
Katinka M Snoek, Régine P M Steegers-Theunissen, René A Klaassen, Joop S E Laven, Sam Schoenmakers. Impact of Bariatric surgery on EmbrYONic, fetal and placental Development (BEYOND): protocol for a prospective cohort study embedded in the Rotterdam periconceptional cohort. BMJ Open 2021; 11(9): e051110 doi: 10.1136/bmjopen-2021-051110
|
| 18 |
Andrew Whang, Ravinder Nagpal, Hariom Yadav. Bi-directional drug-microbiome interactions of anti-diabetics. EBioMedicine 2019; 39: 591 doi: 10.1016/j.ebiom.2018.11.046
|
| 19 |
Celien Kuiper-Makris, Jaco Selle, Eva Nüsken, Jörg Dötsch, Miguel A. Alejandre Alcazar. Perinatal Nutritional and Metabolic Pathways: Early Origins of Chronic Lung Diseases. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.667315
|
| 20 |
Koy Min Chue, Sunny Hei Wong, Tao Zuo, Yusuf Ali. The role of the gut non-bacterial microbiome (virome, mycobiome, archaeome) and its impact on obesity. Molecular Metabolism 2026; 103: 102289 doi: 10.1016/j.molmet.2025.102289
|
| 21 |
Zhongmin Yang, Mingyue Yang, Edward C. Deehan, Chenxi Cai, Karen L. Madsen, Eytan Wine, Guiling Li, Jian Li, Jingwen Liu, Zhengxiao Zhang. Dietary fiber for the prevention of childhood obesity: a focus on the involvement of the gut microbiota. Gut Microbes 2024; 16(1) doi: 10.1080/19490976.2024.2387796
|
